William Williams

William Williams

Algemeen Directeur bij BRIACELL THERAPEUTICS CORP.

Vermogen: 335 185 $ op Vandaag

68 jaar
Health Technology
Consumer Services
Finance

Oorsprong van het eerstegraads netwerk van William Williams

EntiteitType entiteitIndustrie
University of Pennsylvania
856
College/University Other Consumer Services 856
Public Company Pharmaceuticals: Major 41
Public Company Biotechnology 13
10
Subsidiary Pharmaceuticals: Major 10
BriaPro Therapeutics Corp.
3
Unknown 3

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met William Williams via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
The Wharton School of the University of Pennsylvania College/University

Jean-Jacques Bienaimé

James S. Riepe

Evan S. Melrose

Kristy Cunningham

Masters Business Admin

Masters Business Admin

Masters Business Admin

Undergraduate Degree

Harvard Business School College/University

Samir Arun Lakhani

Erin Lantz

Kristy Cunningham

Lisa Shapiro Strovink

Masters Business Admin

Masters Business Admin

Masters Business Admin

Graduate Degree

Columbia Business School College/University

Alex Norton

Paul Clancy

Scott M. Gallin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Pharmaceuticals: Major

Herve Hoppenot

Steven Stein

Vijay Iyengar

President

Corporate Officer/Principal

Corporate Officer/Principal

The Leonard N Stern School of Business College/University

Richard Berman

John Fry

Gregory Z. Rush

Masters Business Admin

Masters Business Admin

Masters Business Admin

Pharmaceuticals: Major

Herve Hoppenot

Steven Stein

Vijay Iyengar

President

Corporate Officer/Principal

Corporate Officer/Principal

MERCK & CO., INC. Pharmaceuticals: Major

Wendy Dixon

Marc Lustig

Bryant Lim

Sales & Marketing

Corporate Officer/Principal

General Counsel

Pharmaceuticals: Major

Richard de Schutter

Richard Levy

Rebecca Taub

Chief Executive Officer

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Wendy Dixon

Rebecca Taub

Sales & Marketing

Corporate Officer/Principal

LaSalle University College/University

Scott W. Hurley

Martin Schmieg

Graduate Degree

Undergraduate Degree

University of Cambridge College/University

Wendy Dixon

Robert J. Borghese

Doctorate Degree

Graduate Degree

Investment Managers

Ron Mordechai Lior

David Francis Betten

Portfolio Manager-Equities

Portfolio Manager-Equities

McGill University College/University

David Vurgait

Marc Lustig

Graduate Degree

Graduate Degree

PRELUDE THERAPEUTICS INCORPORATED Biotechnology

Krishna Vaddi

Bryant Lim

Founder

Director of Finance/CFO

Medical Specialties

Jean-Jacques Bienaimé

David Hastings

Director/Board Member

Comptroller/Controller/Auditor

Harvard Medical School College/University

Rebecca Taub

Vijay Iyengar

Corporate Officer/Principal

Doctorate Degree

Investment Managers

Alex Norton

Laura Heins

Portfolio Manager-Equities

Analyst-Equity

MADRIGAL PHARMACEUTICALS, INC. Pharmaceuticals: Major

Richard Levy

Rebecca Taub

Director/Board Member

Founder

Investment Banks/Brokers

Alex Norton

Bill Belleville

Corporate Officer/Principal

Corporate Officer/Principal

VAXIL BIO LTD. Biotechnology

Saeid Babaei

Gadi Levin

Chairman

Chief Executive Officer

Investment Managers

Richard de Schutter

Scott M. Gallin

Private Equity Investor

Private Equity Investor

College/University

David Badler

Carlo Portes

Masters Business Admin

Masters Business Admin

Miscellaneous Commercial Services

Roy Whitfield

David Badler

Corporate Officer/Principal

Private Equity Analyst

Stanford University College/University

Roy Whitfield

Vijay Iyengar

Masters Business Admin

Undergraduate Degree

University of Oxford College/University

Roy Whitfield

Michael Charles A. Booth

Undergraduate Degree

Doctorate Degree

Brown University College/University

Richard Levy

Joel Lloyd Gantcher

Undergraduate Degree

Undergraduate Degree

PROTARA THERAPEUTICS, INC. Pharmaceuticals: Major

Barry Flannelly

Richard Levy

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Barry Flannelly

Vijai P. Mohan

Corporate Officer/Principal

Corporate Officer/Principal

NEKTAR THERAPEUTICS Pharmaceuticals: Major

Barry Flannelly

Roy Whitfield

Corporate Officer/Principal

Director/Board Member

David Geffen School of Medicine College/University

Richard Levy

Charles L. Wiseman

Corporate Officer/Principal

Doctorate Degree

Perelman School of Medicine College/University

Richard Levy

Rebecca Taub

Doctorate Degree

Corporate Officer/Principal

The Indiana University School of Medicine College/University

Evan S. Melrose

Guiseppe Del Priore

Doctorate Degree

Corporate Officer/Principal

Pharmaceuticals: Major

Jean-Jacques Bienaimé

Herve Hoppenot

Director/Board Member

Director/Board Member

Franklin & Marshall College College/University

John Fry

Eric Siegel

President

Undergraduate Degree

College/University

Bill Belleville

Rich Ballew

Undergraduate Degree

Undergraduate Degree

Investment Banks/Brokers

Bill Belleville

Helen Remeza

Corporate Officer/Principal

Market Strategist

Miscellaneous Commercial Services

Jean-Jacques Bienaimé

Herve Hoppenot

Director/Board Member

Director/Board Member

Investment Banks/Brokers

Marc Lustig

Jamieson Bondarenko

Corporate Officer/Principal

Corporate Officer/Principal

University of Cape Town College/University

Gadi Levin

Undergraduate Degree

Miscellaneous Commercial Services

Carol R. Scheman

Director/Board Member

College/University

Carol R. Scheman

Corporate Officer/Principal

Uniformed Services University of the Health Sciences College/University

Carol R. Scheman

Corporate Officer/Principal

Statistieken

Internationaal

Verenigde Staten 44
Canada 5
Verenigd Koninkrijk 3
Zuid-Afrika 2

Sectoraal

Consumer Services 21
Health Technology 15
Finance 11
Commercial Services 4
Transportation 2

Operationeel

Director/Board Member 316
Corporate Officer/Principal 169
Independent Dir/Board Member 103
Undergraduate Degree 92
Chairman 58
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU